US Oil Producers Ramp Up Drilling to Capitalize on Price Surge Amid Iran Conflict Vodafone Idea Leads Midcap Rally as Six Stocks Hit 52Week Highs with Up to 50 Monthly Gains Broad AILed Selloff Hits Wall Street as Chinas DeepSeek Spurs Rout SP 500 Earnings and Revenue Growth Accelerates Says Oppenheimer Retail Earnings Flood This Week as Dollar Tree Gap and AI Players Like Dell Report Nike Stock Rebound Prospects Remain Uncertain Amid Ongoing Challenges Cullinan Therapeutics Inc CGEM Q1 2026 Earnings Beat on EPS with NarrowerThanExpected Loss Sonic Automotive SAH Q1 2026 Earnings EPS Surprises to the Upside Shares Gain Ground Actinium Pharmaceuticals ATNM Q1 2026 Earnings NarrowerThanExpected Loss as Pipeline Advances Continue TBRG Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher Despite Disappointing Quarter ARAI Q1 2026 Earnings NarrowerthanExpected Loss Fails to Halt Share Decline Franklin Financial Services Corporation FRAF Q1 2026 Earnings Solid EPS Beat Lifts Sentiment Outlook Cautious MainStreet Bancshares Inc MNSB Holds Steady Near 23 Key Levels in Focus Gencor Industries GENC Holds Steady Near Support After Marginal Decline AGNCL Holds Near 2484 Amid Modest Decline Preferred Stock Maintains Stability ConAgra Brands CAG Falls 3 as Consumer Staples Face Pressure Launchpad Cadenza Acquisition Corp I LPCVU Surges 48 Approaching Key Resistance at 1107 Solaris Resources SLSR Advances 55 as Bullish Momentum Builds Toward Resistance Vendome Acquisition Corporation I VNME Holds Steady at 1017 SPAC Stability in Focus Pluri Inc PLUR Posts Modest Gain as Stock Holds Above Key Support Estrella Immunopharma ESLA Slips 26 as Stock Tests Key Support Near 106 Perceptive Capital Solutions Corp PCSC Posts Modest Gain Approaches Key Resistance Level Humana HUM Edges Higher as Shares Test Key Resistance Levels Samsung Strike Suspended as Union Votes on Tentative Deal Amid AI Bonus Demands KimberlyClark Q1 2026 Earnings EPS Beats Estimates Amid Flat Revenue and Marginal Stock Decline Fulcrum Therapeutics FULC Edges Higher as Biotech Sentiment Stabilizes